LLY

1,000.74

-0.73%↓

JNJ

243.67

+0.49%↑

ABBV

226.66

-0.51%↓

NVS

161.54

-0.79%↓

AZN

195.13

+0.21%↑

LLY

1,000.74

-0.73%↓

JNJ

243.67

+0.49%↑

ABBV

226.66

-0.51%↓

NVS

161.54

-0.79%↓

AZN

195.13

+0.21%↑

LLY

1,000.74

-0.73%↓

JNJ

243.67

+0.49%↑

ABBV

226.66

-0.51%↓

NVS

161.54

-0.79%↓

AZN

195.13

+0.21%↑

LLY

1,000.74

-0.73%↓

JNJ

243.67

+0.49%↑

ABBV

226.66

-0.51%↓

NVS

161.54

-0.79%↓

AZN

195.13

+0.21%↑

LLY

1,000.74

-0.73%↓

JNJ

243.67

+0.49%↑

ABBV

226.66

-0.51%↓

NVS

161.54

-0.79%↓

AZN

195.13

+0.21%↑

Search

Quanterix Corp

Închisă

SectorSănătate

5 -1.57

Rezumat

Modificarea prețului

24h

Curent

Minim

4.9

Maxim

5.22

Indicatori cheie

By Trading Economics

Venit

10M

-23M

Vânzări

3.7M

44M

Marjă de profit

-52.712

Angajați

450

EBITDA

16M

-16M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+48.22% upside

Dividende

By Dow Jones

Următoarele câștiguri

11 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-56M

239M

Deschiderea anterioară

6.57

Închiderea anterioară

5

Sentimentul știrilor

By Acuity

57%

43%

270 / 351 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Quanterix Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

10 mar. 2026, 20:38 UTC

Câștiguri

Oracle Raises 2027 Sales Outlook Amid AI Demand, Restructuring

10 mar. 2026, 23:57 UTC

Market Talk

Global Equities Roundup: Market Talk

10 mar. 2026, 23:57 UTC

Market Talk

Risks Rising on Australian Bank Valuation Multiples -- Market Talk

10 mar. 2026, 23:47 UTC

Market Talk

Nikkei May Rise as Concerns About Energy Costs Ease -- Market Talk

10 mar. 2026, 23:37 UTC

Achiziții, Fuziuni, Preluări

Yangzijiang Shipbuilding to Acquire Poseidon Stake for US$825.7M

10 mar. 2026, 23:37 UTC

Achiziții, Fuziuni, Preluări

Yangzijiang Shipbuilding to Buy 10% Stake in Poseidon

10 mar. 2026, 23:37 UTC

Achiziții, Fuziuni, Preluări

Yangzijiang Shipbuilding to Fund Deal With Internal Cash Resources

10 mar. 2026, 23:37 UTC

Achiziții, Fuziuni, Preluări

Yangzijiang Shipbuilding to Buy Stake From Fairfax, Washington Family Affiliates

10 mar. 2026, 23:35 UTC

Market Talk
Evenimente importante

Gold Edges Higher as It Faces Opposing Forces -- Market Talk

10 mar. 2026, 23:06 UTC

Câștiguri

Oracle Raises 2027 Sales View as AI Demand Outpaces Supply -- Update

10 mar. 2026, 22:51 UTC

Evenimente importante

Deleted Tweet From Energy Secretary Sends Oil Markets on Another Wild Ride -- Updated

10 mar. 2026, 21:39 UTC

Achiziții, Fuziuni, Preluări

Bill Ackman Has a Stroke of Genius. Buy His New Fund and Get Shares of His Pershing Square IPO. -- Barrons.com

10 mar. 2026, 21:21 UTC

Câștiguri

Oracle Stock Jumps on Earnings Beat. Its Cloud Business Is Taking Over. -- Barrons.com

10 mar. 2026, 21:15 UTC

Câștiguri

Franco-Nevada: 2026 Total GEOs Expected to Range From 510,000 to 570,000 Ounces

10 mar. 2026, 21:15 UTC

Achiziții, Fuziuni, Preluări

Paramount Skydance's Stock Fades. The Warner Bros. Merger Will Take Years to Pay Off, BofA Says. -- Barrons.com

10 mar. 2026, 21:14 UTC

Câștiguri

Franco-Nevada: Methodology Replaces Previous Variable GEO Conversion Ratios Based on Prevailing Market Prices

10 mar. 2026, 21:13 UTC

Câștiguri

Franco-Nevada: Beginning in 2026, Company Will Be Adopt Fixed GEO Conversion Ratios Based on the Pricing Assumptions Outlined in 2026 Guidance

10 mar. 2026, 21:12 UTC

Câștiguri

Franco-Nevada 4Q Rev $597.3M >FNV

10 mar. 2026, 21:12 UTC

Câștiguri

Franco-Nevada 4Q EPS $1.90

10 mar. 2026, 20:57 UTC

Câștiguri

Oracle Stock Jumps on Earnings Beat -- Barrons.com

10 mar. 2026, 20:50 UTC

Market Talk
Câștiguri

Tech, Media & Telecom Roundup: Market Talk

10 mar. 2026, 20:44 UTC

Câștiguri

Oracle Stock Jumps on Earnings Beat -- Barrons.com

10 mar. 2026, 20:34 UTC

Market Talk
Câștiguri

Global Equities Roundup: Market Talk

10 mar. 2026, 20:34 UTC

Market Talk
Câștiguri

Oracle Building More Software for Less Money After Restructuring -- Market Talk

10 mar. 2026, 20:23 UTC

Câștiguri

Oracle Stock Jumps on Earnings Beat -- Barrons.com

10 mar. 2026, 20:16 UTC

Câștiguri

NIO Stock Jumps After Earnings. How the EV Maker Delivered a Surprise Profit. -- Barrons.com

10 mar. 2026, 20:14 UTC

Câștiguri

Oracle Has Not Yet Initiated At-The-Market Equity Portion of Financing Program >ORCL

10 mar. 2026, 20:14 UTC

Câștiguri

Oracle Said In February It Intends to Raise Up to $50 B Dollars in Debt and Equity Financing >ORCL

10 mar. 2026, 20:13 UTC

Câștiguri

Oracle Raised $30 B Through Combination of Investment Grade Bonds and Mandatory Convertible Preferred Stk Within Days of Feb Announcement >ORCL

10 mar. 2026, 20:12 UTC

Câștiguri

Oracle Stock Jumps on Earnings Beat -- Barrons.com

Comparație

Modificare preț

Quanterix Corp Așteptări

Obiectiv de preț

By TipRanks

48.22% sus

Prognoză pe 12 luni

Medie 7.5 USD  48.22%

Maxim 8 USD

Minim 7 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruQuanterix Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

2 ratings

0

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

5.34 / 6.015Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

Bullish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

270 / 351 Clasament în Sănătate

Sentimentul știrilor

Evidențe de scădere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat